CD79A and infection: The observed reduction in diarrhea scores is likely due to the priming dose of the replicating vaccine-induced intestinal IgA and effector T cells, which can prevent or reduce infection, in combination with circulating antibody responses, which are responsible for the reduction of viremia to reduce the perpetuation of HRV infection in the intestine [41].